About Beijing Leadman Biochemistry
Beijing Leadman Biochemistry is a publicly listed company based in Beijing (China) founded in 1997. Manufacturer of in vitro diagnostic equipment, biochemical raw materials, and medical instruments among others. The company has 468 employees. Beijing Leadman Biochemistry has completed 1 acquisition, including DiaSys Diagnostic Systems. Its chief executive, as recorded, is Shen Guangqian. Its focus areas include Traditional Diagnostics.
Company details
Beijing Leadman Biochemistry was established in 1997 in Beijing, China, within the biotechnology and medical devices sector. Operations focus on the production of in vitro diagnostic equipment, biochemical raw materials, and various medical instruments. The company maintains its domain at leadmanbio.com and is led by CEO Shen Guangqian. Activities are centered in China, supporting diagnostic and healthcare applications through these core manufacturing processes.
- Headquarters Beijing, China
- Employees 468
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website leadmanbio.com
- Legal Name Beijing Leadman Biochemistry Co., Ltd. Class A
- Annual Revenue$46.28 M (USD)-9.88as on Dec 31, 2025
- Net Profit-$3.28 M (USD)69.4as on Dec 31, 2025
- EBITDA$3.4 M (USD)8.36as on Dec 31, 2025
- Employee Count468
- Investments & Acquisitions
People of Beijing Leadman Biochemistry
1 people are tracked at Beijing Leadman Biochemistry (1 in leadership); the tracked headcount is 468.
| Name | Role | Group |
|---|---|---|
Shen Guangqian | CEO | Leadership |
Complete people profiles for Beijing Leadman Biochemistry
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Beijing Leadman Biochemistry
Beijing Leadman Biochemistry is a publicly listed company on the SZSE with ticker symbol 300289 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Feb 2012
- Listed onSZSE: 300289
- Listed entityBeijing Leadman Biochemistry Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100001C22
- Share price5.97 CNY (-2.61% on the day) · 2026-10-14
- Market capitalisation3,314,845,453.00 CNY
- EPS (diluted, trailing year)-0.05 CNY
- Volume (last session)4,837,700
Financials of Beijing Leadman Biochemistry
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 324.0M CNY | -23.0M CNY | 23.8M CNY |
| 2024 | 359.6M CNY | -75.1M CNY | 22.0M CNY |
| 2023 | 449.8M CNY | 15.3M CNY | 82.0M CNY |
| 2022 | 693.3M CNY | -56.3M CNY | 77.7M CNY |
| 2021 | 553.0M CNY | 22.4M CNY | 123.4M CNY |
Detailed financial statements for Beijing Leadman Biochemistry
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beijing Leadman Biochemistry
Beijing Leadman Biochemistry has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DiaSys Diagnostic Systems.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of instruments, reagents and kits for the life science industry | diasys-diagnostics.com | Holzheim, Germany | 1991 | Sep 2014 | •••• |
Complete acquisition details for Beijing Leadman Biochemistry
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Beijing Leadman Biochemistry
3 dated milestones of Beijing Leadman Biochemistry across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Beijing Leadman Biochemistry is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires DiaSys Diagnostic Systems.
Web traffic of Beijing Leadman Biochemistry
The website of Beijing Leadman Biochemistry (leadmanbio.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 19.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Beijing Leadman Biochemistry
Complete news archive for Beijing Leadman Biochemistry
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beijing Leadman Biochemistry
Beijing Leadman Biochemistry was founded in 1997.
Beijing Leadman Biochemistry is headquartered in Beijing, China.
Shen Guangqian is the CEO of Beijing Leadman Biochemistry, as recorded in our data.
Beijing Leadman Biochemistry has 468 employees.
Annual revenue of Beijing Leadman Biochemistry is $46.28M as on Dec 31, 2025.
Beijing Leadman Biochemistry was established in 1997 in Beijing, China, within the biotechnology and medical devices sector. Operations focus on the production of in vitro diagnostic equipment, biochemical raw materials, and various medical instruments. The company maintains its domain at leadmanbio.com and is led by CEO Shen Guangqian. Activities are centered in China, supporting diagnostic and healthcare applications through these core manufacturing processes.
Yes, Beijing Leadman Biochemistry is publicly traded on SZSE under the ticker symbol 300289.
Beijing Leadman Biochemistry has made 1 acquisition, including DiaSys Diagnostic Systems.